Effect of auxiliary substances on complexation efficiency and intrinsic dissolution rate of gemfibrozil-β-CD complexes

AAPS PharmSciTech

Volumn 11, Issue 1, 2010, Pages 27-35

  Sami, Fareen ^a   Philip, Betty ^b   Pathak, Kamla ^a  

^a Rajiv Academy for Pharmacy ^*  (India)

^b David Memorial College of Pharmacy   (India)

Author keywords

Auxiliary substances; Complexation efficiency; Cyclodextrins; Gemfibrozil; Intrinsic dissolution rate; Stability constant

Indexed keywords

BETA CYCLODEXTRIN; GEMFIBROZIL; POVIDONE; TRIETHANOLAMINE;

ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; FREEZE DRYING; INFRARED SPECTROSCOPY; POWDER DIFFRACTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCANNING ELECTRON MICROSCOPY; SOLID STATE; SOLUBILITY; X RAY DIFFRACTION;

BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; FREEZE DRYING; GEMFIBROZIL; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ELECTRON, SCANNING; PHARMACEUTICAL PREPARATIONS; PHARMACEUTICAL SOLUTIONS; POLYMERS; POVIDONE; SOLUBILITY; X-RAY DIFFRACTION; X-RAYS;

EID: 77950917310     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9350-y     Document Type: Article

References (33)

1. ML Manca M Zaru G Ennas, et al. 2005 Diclofenac-β-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and diffusion studies AAPS PharmSci Tech 6 64 72
2. R Challa A Ahuja RK Khar J Ali 2005 Cyclodextrins in drug delivery: an updated review AAPS Pharm Sci Tech 6 E326 E338 10.1208/pt060243 (Pubitemid 41631739)
3. T Loftsson M Masson JF Siigurjonsdottir 1999 Methods to enhance the complexation efficiency of cyclodextrins STP Pharma Sci 9 237 242 1:CAS:528:DyaK1MXlsleiu7s%3D
4. T Loftsson ME Brewster 1996 Pharmaceutical applications of cyclodextrins. Drug solubilization and stabilization J Pharm Sci 85 1017 1025 10.1021/js950534b 1:CAS:528:DyaK28XlsFSrsr4%3D 8897265 (Pubitemid 26338912)
5. K Ukama M Otagiri 1987 Cyclodextrins in drug carrier systems Chem Rev 98 2045 2076 10.1021/cr970025p
6. ST Ulu 2006 LC determination of gemfibrozil in tablets Chromatographia 64 447 10.1365/s10337-006-0057-x 1:CAS:528:DC%2BD2sXhslKitLg%3D (Pubitemid 44521408)
7. S Ain B Philip K Pathak 2008 Preformulative assessment of inclusion complexes of Gemfibrozil, with cyclodextrins PDA 62 300 308 1:CAS:528: DC%2BD1cXht1Wlsr%2FN
8. AR Patel PR Vavia 2006 Effect of hydrophilic polymers on solubilization of fenofibrate by cyclodextrin complexation J Inc Phenom Macrocycl Chem 56 247 251 10.1007/s10847-006-9091-4 1:CAS:528:DC%2BD28XhtFSitrfN
9. T Loftsson H Fridriksdottir 1996 The effect of water soluble polymers on aqueous solubility of drugs Int J Pharm Sci 127 293 296 10.1016/0378-5173(95) 04207-5 1:CAS:528:DyaK28XitVCnsb4%3D (Pubitemid 26092141)
10. Higuchi T, Connors A. Phase solubility techniques. Adv Anal Chem Instrum. 1965; 117-211
11. T Loftsson D Hreinsdottir M Masson 2007 The complexation efficiency J Inc l Phenom Macrocycl Chem 57 545 552 10.1007/s10847-006-9247-2 1:CAS:528:DC%2BD2sXjs12lurc%3D
12. SSR Laura CF Dominos JBV Francisco 2003 Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with β-cyclodextrin and its sulfobutyl ether derivative in solution and solid state Eur J Pharm Sci 20 253 266 10.1016/S0928-0987(03)00199-4 (Pubitemid 37338531)
13. KPR Chowdary SV Srinivas 2006 Effect of polyvinylpyrrolidone on complexation and dissolution rate of β and hydroxypropyl-β- cyclodextrin complexes of celecoxib Ind J Pharm 68 631 634 10.4103/0250-474X. 29632 1:CAS:528:DC%2BD2sXhtVKhurnJ
14. R Govindarajan S Nagarsenkar 2004 Influence of preparation methodology on solid state properties of an acidic drug-cyclodextrin system J Pharm Pharmacol 56 725 733 10.1211/0022357023538 1:CAS:528:DC%2BD2cXmtFSks7k%3D 15231037 (Pubitemid 38801688)
15. Aulton M. Pharmaceutical preformulation: the physicochemical properties of drug substances. Pharmaceutics the design of dosage form design. 2nd ed. Philadelphia: Churchill Livingstone; 2002. p. 122-3.
16. KPR Chowdary SV Srinivas 2006 Influence of hydrophilic polymer on celecoxib complexation with hydroxypropyl-β-CD AAPS Pharm Sci Tech 7 E1 E5 10.1208/pt070379 (Pubitemid 44548844)
17. T Yamakawa S Nishimura 2003 Liquid formulation of a novel non-fluorinated topical quinolone, T-3912, utilizing the synergistic solubilizing effect of the combined use of magnesium ions and hydroxypropyl-β-cyclodextrin J Cont Release 86 101 113 10.1016/S0168-3659(02)00367-X 1:CAS:528:DC%2BD38XpsFSjs70%3D (Pubitemid 35461977)
18. G Granero C Garnero L Marcela 2003 The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-β-cyclodextrin Eur J Pharm Sci 20 285 293 10.1016/S0928-0987(03)00202-1 1:CAS:528:DC%2BD3sXosVyltrk%3D (Pubitemid 37338534)
19. H Fridriksdottir AM Siiguroardottir H Ueda 1994 The effect of water soluble polymers on drug-cyclodextrin complexation Int J Pharm 110 169 177 10.1016/0378-5173(94)90155-4 (Pubitemid 24248089)
20. P Mura MT Faucci GP Bettinetti 2001 The influence of polyvinyl pyrrolidone on naproxen complexation with hydroxypropyl β-cyclodextrin Eur J Pharm Sci 13 187 194 10.1016/S0928-0987(01)00093-8 1:CAS:528: DC%2BD3MXisF2qs7Y%3D 11297903 (Pubitemid 32288788)
21. A PRODUCT GUIDE Performance Enhancing Products for Pharmaceuticals Available at www.ispcorp.com. Accessed March 8, 2008.
22. Kollidon BW. Polyvinylpyrrolidone for the pharmaceutical industry 4th edn. BASF; 1998.
23. RC Doijad MM Kanakal FV Manvi 2007 Effect of processing variables on dissolution and solubility of piroxicam: hydroxypropyl-β-cyclodextrin inclusion complexes Indian J Pharm S 69 323 326 10.4103/0250-474X.33175 1:CAS:528:DC%2BD1MXhtVGqsLbN
24. CLC Dollo, et al. 1999 Improvement in solubility and dissolution rate of 1, 2-dithiole-3-iones upon complexation with β-cyclodextrin and its hydroxypropyl and sulfobutylether derivatives J Pharm Sci 88 889 895 10.1021/js990067o 1:CAS:528:DyaK1MXltFSrtrg%3D 10479350 (Pubitemid 29438952)
25. GEL Ahmed 1998 Effect of cyclodextrins on the physico-chemical properties and antimycotic activity of clotrimoxazole Int J Pharm 171 111 121 10.1016/S0378-5173(98)00163-X 1:CAS:528:DyaK1cXlsVyitbc%3D (Pubitemid 28410252)
26. M Kurazumi N Nambu T Nagri 1975 Pharmaceutical interactions in dosage form and processing for Inclusion compounds of non-steroidal anti-inflammatory and other slightly water soluble drugs with β-cyclodextrins in powdered form Chem Pharm Bull 23 3062 3068
27. F Veiga C Fernandes P Maincent 2001 Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary system Drug Dev Ind Pharm 27 523 532 10.1081/DDC-100105177 1:CAS:528:DC%2BD3MXmslSrsL8%3D 11548859 (Pubitemid 32803571)
28. C Fernandes MT Viera F Viega 2002 Physicochemical characterization and in vitro dissolution behaviour of nicardipine-cyclodextrin inclusion compounds Eur J Pharm Sci 15 79 88 10.1016/S0928-0987(01)00208-1 1:CAS:528: DC%2BD38Xms1Glsg%3D%3D 11803134 (Pubitemid 34136971)
29. JA Ryan 1986 Compressed pellet X-RD monitoring for optimization of crystallinity in lyophilized solids: imipenem: cilastatin sodium case J Pharm Sci 75 805 807 10.1002/jps.2600750817 1:CAS:528:DyaL2sXptVSmtw%3D%3D 3464737
30. BN Nalluri KPR Chowdhary KVR Murthy, et al. 2003 Physicochemical characterization and dissolution properties of nimesulide-cyclodextrin binary system AAPS PharmSci Tech 4 1 12
31. VM Rao JL Haslam VJ Stella 2001 Controlled and complete release of model poorly water soluble drug, prednisolone, from hydroxypropylmethylcellulose matrix tablets using SBE-β-cyclodextrin as a solubilizing agent J Pharm Sci 129 807 816 10.1002/jps.1034 (Pubitemid 32645939)
32. S Baboota M Dhaliwal K Kohli, et al. 2005 Inclusion complexation of Rofecoxib with dimethyl β-cyclodextrin J Pharm Sci 85 226 229
33. N Erden N Celebi 1988 A study of inclusion complex of naproxen with β-cyclodextrin Int J Pharm 48 83 89 10.1016/0378-5173(88)90250-5 1:CAS:528:DyaL1MXhtVWmu7c%3D